Related Experiment Video
Updated: Jun 23, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits
Emilie A Chapeau1, Laurent Sansregret2, Giorgio G Galli2
1Novartis BioMedical Research, Basel, Switzerland. emilie.chapeau@novartis.com.
No abstract available in PubMed .
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Experimental RNAi
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway